Sentence examples for reduced hematoma from inspiring English sources

They found that CCL2 or CCR2 deletion reduced hematoma size in a mouse collagenase ICH model, reduced early microglial activation/migration but increased microglia numbers later after ICH.

In a mouse model of intracerebral hemorrhage, administration of Necrostatin-1 significantly reduced hematoma volume, neuronal cell death, reactive astrogliosis and neurovascular injury.

In a retrospective comparison of deep-plane face-lift surgery with (n = 459) and without (n = 146) fibrin sealant, 35 adhesive treatment was associated with a significantly reduced hematoma rate, 0.45% versus 3.4% (P = 0.01).

Compared with CEA, CAS reduced hematoma, periprocedural myocardial infarction, and cranial nerve palsy, while it was associated with higher risks of both short-term and long-term nondisabling stroke.

CAS reduced hematoma, periprocedural MI, and cranial nerve palsy, while it was associated with a higher risk of nondisabling stroke of both short-term and long-term period in elderly patients with severe and symptomatic carotid stenosis.

A drop in FXIII activity has previously been associated with reduced hematoma growth in patients not on VKA, suggesting that consumption of FXIII stabilizes clots.

Clinical Question: Does early, intensive lowering of blood pressure reduce hematoma volume and improve clinical outcome after acute cerebral hemorrhage?

Intraventricular administration of the plasminogen activator urokinase every 12 hours may reduce hematoma size and the expected mortality rate at 1 month [ 135].

Recombinant activated factor VIIa (rFVIIa) can effectively reduce hematoma growth and improve outcomes when given within 4 hours of symptom onset in patients with acute intracerebral hemorrhage.

Early intensive blood pressure-lowering treatment is clinically feasible, well tolerated, and appears to reduce hematoma growth in acute intracerebral hemorrhage (ICH) [ 4].

The size of the hematoma is directly related to outcome [ 3] and measures that have the potential to reduce hematoma growth, typically due to early rebleeding, may reduce morbidity and mortality.